Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company
Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company
Home > Investor Relations > Corporate Governance > Insider Transactions

Insider Transactions

Date Name Title Type Sorted Ascending Shares Traded Price Range
Mar 25, 2014 allen lee f md phd Officer Acquisition (Non Open Market) 8,000 n/a
May 8, 2014 allen lee f md phd Officer Acquisition (Non Open Market) 20,000 n/a
Feb 18, 2015 allen lee f md phd Officer Acquisition (Non Open Market) 15,000 n/a
Dec 19, 2012 arora krishan k Director Acquisition (Non Open Market) 10,000 11.34
Dec 13, 2013 cohen raymond w Director Acquisition (Non Open Market) 10,000 n/a
Jun 27, 2014 cohen raymond w Director Acquisition (Non Open Market) 10,000 n/a
Jun 29, 2015 cohen raymond w Director Acquisition (Non Open Market) 10,000 n/a
Jun 28, 2016 cohen raymond w Director Acquisition (Non Open Market) 10,000 n/a
Jun 13, 2017 cohen raymond w Director Acquisition (Non Open Market) 10,000 n/a
Jul 20, 2007 cybulski mitchell p. Director Acquisition (Non Open Market) 5,000 n/a
Jul 20, 2007 fulmer richard Director Acquisition (Non Open Market) 5,000 n/a
Jul 15, 2008 fulmer richard Director Acquisition (Non Open Market) 7,500 1.44
Dec 19, 2012 gagnon gilles Director Acquisition (Non Open Market) 10,000 11.34
Dec 13, 2013 gagnon gilles Director Acquisition (Non Open Market) 10,000 n/a
Jun 27, 2014 gagnon gilles Director Acquisition (Non Open Market) 10,000 n/a
Jun 29, 2015 gagnon gilles Director Acquisition (Non Open Market) 10,000 n/a
Jun 13, 2017 gagnon gilles Director Acquisition (Non Open Market) 10,000 n/a
Dec 19, 2012 gueth anton Director Acquisition (Non Open Market) 10,000 11.34
Jun 3, 2013 gustafson kurt a Officer Acquisition (Non Open Market) 100,000 n/a
Mar 25, 2014 gustafson kurt a Officer Acquisition (Non Open Market) 15,000 n/a
Showing 1-20 of 267 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14  See Next 20

Stock transaction information provided by EDGAR Online. Spectrum Pharmaceuticals, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.

Back to top

Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company

NASDAQ: SPPI

Price:
19.50
Change:
- 1.23
Day High:
21.00
Day Low:
19.10
Volume:
2,141,818
4:00 PM ET on Nov 17, 2017
Delayed at least 20 minutes.
Provided by eSignal.

Shareholder Tools

Print Email

Search IR